Characteristic | Group A | Group B | P |
---|---|---|---|
(n = 616, 85 %) | (n = 109, 15 %) | (χ 2 test) | |
Age (years) | |||
≤65 | 564 (77.79 %) | 92 (12.69 %) | |
>65 | 52 (7.17 %) | 17 (2.34 %) | 0.019 |
Sex | |||
Male | 452 (62.34 %) | 87 (12.00 %) | |
Female | 164 (22.62 %) | 22 (3.03 %) | 0.156 |
Smoking history | |||
Yes | 377 (52.00 %) | 75 (10.34 %) | |
No | 239 (32.97 %) | 34 (4.69 %) | 0.131 |
History of alcohol consumption | |||
Yes | 205 (28.28 %) | 45 (6.21 %) | 0.091 |
No | 411 (56.69 %) | 63 (8.69 %) | |
Tumor length (cm) | |||
≤5 | 474 (65.38 %) | 52 (7.17 %) | <0.001 |
>5 | 132 (18.21 %) | 57 (7.86 %) | |
Intraoperative blood loss (ml) | |||
≤200 | 471 (64.97 %) | 77 (10.62 %) | |
>200 | 143 (19.72 %) | 31 (4.28 %) | 0.225 |
pTNM stage | |||
I | 92 (12.69 %) | 11 (1.52 %) | |
II | 299 (41.24 %) | 46 (6.34 %) | |
III | 225 (31.03 %) | 52 (7.17 %) | 0.069 |
Venous invasion | |||
Absence | 603 (83.17 %) | 107 (14.76 %) | |
Presence | 13 (1.79 %) | 2 (0.28 %) | 0.852 |
Lymph node metastasis | |||
Absence | 332 (45.79 %) | 56 (7.72 %) | |
Presence | 284 (39.17 %) | 53 (7.31 %) | 0.627 |